Patents by Inventor Hester Visser

Hester Visser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Levodopa dosing regimen
    Patent number: 11986449
    Abstract: The invention provides oral dosing regimens of controlled release levodopa compositions for use in treating patients with Parkinson's disease, primary parkinsonism/idiopathic parkinsonism, post-encephalitic parkinsonism, parkinsonism that may follow carbon monoxide intoxication, or parkinsonism that may follow manganese intoxication.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: May 21, 2024
    Assignee: Amneal Pharmaceuticals LLC
    Inventors: Richard D'Souza, Hester Visser, Suneel Gupta
  • LEVODOPA DOSING REGIMEN
    Publication number: 20230054825
    Abstract: The invention provides oral dosing regimens of controlled release levodopa compositions for use in treating patients with Parkinson's disease, primary parkinsonism/idiopathic parkinsonism, post-encephalitic parkinsonism, parkinsonism that may follow carbon monoxide intoxication, or parkinsonism that may follow manganese intoxication.
    Type: Application
    Filed: October 17, 2022
    Publication date: February 23, 2023
    Applicant: Amneal Pharmaceuticals LLC
    Inventors: Richard D'Souza, Hester Visser, Suneel Gupta
  • LEVODOPA DOSING REGIMEN
    Publication number: 20220202723
    Abstract: The invention provides oral dosing regimens of controlled release levodopa compositions for use in treating patients with Parkinson's disease.
    Type: Application
    Filed: December 21, 2021
    Publication date: June 30, 2022
    Applicant: Amneal Pharmaceuticals LLC
    Inventors: Richard D'Souza, Hester Visser, Suneel Gupta